Within our niche, ophthalmology, we’ve garnered experience spanning across both the front and back of the eye, including within glaucoma, dry eye, retinitis pigmentosa, and several other indications. In total, we’ve managed 70+ trials of all phases across 19 countries that have included more than 10,000 patients. We’re a continuously growing and evolving company, and we’ve recently become an emerging gene therapy CRO. While gene therapy itself is still a relatively new and developing treatment option for some, Trial Runners has managed gene therapy focused trials that involve very promising treatments and outcomes. We’re extremely proud to be on the cutting-edge of new technology and treatments, and we’re equally as proud to play our part in shaping these clinical trials.
116 West Villard St.
Dickinson, North Dakota 58601